CLINICAL ROLE -
FDA Grants Accelerated Approval to Acalabrutinib for Mantle Cell Lymphoma
Calquence is a kinase inhibitor that blocks an enzyme crucial for cancer growth.
Read More
Mantle Cell Lymphoma Drug Receives FDA Approval
Acalabrutinib (Calquence) found to improve overall response rate among patients with mantle cell lymphoma.
FDA to Revoke Claim that Soy Lowers Heart Disease Risk
Consuming soy-based products may not be as beneficial for heart health as previously thought.
Ozanimod Reduces Annual Relapse Rate in Patients with Multiple Sclerosis
Ozanimod may slow multiple sclerosis progression more than first-line therapy.
Healthcare, Social Services Partnership Could Reduce Spending
Integration of social services into hospital care could connect patients with necessary services.
Avastin Shows Promise as First-Line Therapy for Advanced Ovarian Cancer
Bevacizumab (Avastin) may improve progression-free survival among treatment-naïve patients with ovarian cancer.
Physical Activity May Not Reduce Coronary Artery Calcification Risk
High levels of exercise may not have a significant impact on the development of heart disease.
Cholesterol Harnesses Immune Cells to Facilitate Breast Cancer Metastasis
A byproduct of cholesterol metabolism may fuel the spread of solid tumors.
New Treatments Keep Ulcerative Colitis in Check
Novel biologics are able to control ulcerative colitis symptoms and prevent surgical intervention.
Trending News Today: Benchmark ACA Premiums Set to Rise Nearly 40%
Top news of the day from across the healthcare landscape.
Amazon Disrupts Industry After Obtaining Wholesale Pharmacy Licenses
Pharmacy wholesaler stocks dropped significantly due to concerns over retail giant Amazon entering the pharmacy space.
Opioid Knowledge Gaps Persist Amid Epidemic
Only one-quarter of patients prescribed opioids discussed the potential of addiction with their provider.
Environmental Chemicals Linked to Breast Cancer Risk
Exposure to many chemicals, including gasoline, can heighten the risk of developing breast cancer.
CVS Launches New Performance-Based PBM Network
New network encourages medication adherence for chronic conditions.
EGFR Signaling Could be Harnessed to Fight Cancer
New discovery about EGFR signaling may prevent cancer cells from spreading.
Insufficient Sleep May Lead to Gestational Diabetes
Pregnant women who slept less than 6.5 hours per night were nearly 3 times as likely to develop gestational diabetes.
Trending News Today: Investigation Targets Insulin Manufacturers, PBMs
Trending News Today: House Plans to Vote on CHIP Funding Bill
Study: Engaged Employers More Satisfied with Their PBMs
Analysis shows that more engaged employers work diligently with their pharmacy benefit managers to assure alignment between services and total value.
Employers and PBMs: Where do They Stand on Prescription Drug Issues?
Employers provide coverage for 56% of the insured population, which carries significant weight with pharmacy benefit managers.
ACA Silver Plan Premiums Projected to Increase 34% in 2018
Market instability contributes to increasing premiums for 2018 Affordable Care Act health plans.
Gene Therapy-Immunotherapy Combination Could Reverse Multiple Sclerosis
Combination therapy found to reverse multiple sclerosis in mice models.
Protein Deletion May Eliminate Diabetes Risk
Deleting fatty acid-binding proteins may lead to lifelong metabolic health.
Trending News Today: Trump Declares Opioid Epidemic a Public Health Emergency
Trending News Today: Amazon Receives Pharmacy License in 12 States
Biosimilars Could Save $54 Billion Over the Next Decade
The emergence of biosimilars will reduce spending on biologics by 3% through 2027.
Study: Hospitals Mark-Up Drugs Significantly
Drugs administered in an outpatient setting may be marked-up more than 500%.
PI3K Inhibitors Promising for Rare Bone Cancer Therapy
Genome analysis points to potential new treatments for patients with chordoma.
Men Develop Atrial Fibrillation Earlier Than Women
Atrial fibrillation risk increases in men a decade before women.
Investigational Therapy Induces Cancer Cell Death
Novel drug causes apoptosis in leukemia cells, while leaving healthy blood cells unscathed.